MwanzoHYPMY • OTCMKTS
add
Hypera ADR
Bei iliyotangulia
$ 4.04
Bei za siku
$ 4.22 - $ 4.22
Bei za mwaka
$ 2.64 - $ 5.92
Thamani ya kampuni katika soko
14.45B BRL
Wastani wa hisa zilizouzwa
elfu 267.39
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (BRL) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.15B | -1.60% |
Matumizi ya uendeshaji wa biashara | 649.05M | 0.84% |
Mapato halisi | 426.69M | -13.42% |
Kiwango cha faida halisi | 19.81 | -11.99% |
Mapato kwa kila hisa | 0.68 | -12.82% |
EBITDA | 694.71M | -2.19% |
Asilimia ya kodi ya mapato | 1.82% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (BRL) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.20B | -57.56% |
Jumla ya mali | 24.24B | -4.47% |
Jumla ya dhima | 12.24B | -8.25% |
Jumla ya hisa | 11.99B | — |
hisa zilizosalia | 632.94M | — |
Uwiano wa bei na thamani | 0.21 | — |
Faida inayotokana na mali | 6.65% | — |
Faida inayotokana mtaji | 7.63% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (BRL) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 426.69M | -13.42% |
Pesa kutokana na shughuli | 442.78M | -29.06% |
Pesa kutokana na uwekezaji | -209.22M | -72.00% |
Pesa kutokana na ufadhili | -770.05M | 8.42% |
Mabadiliko halisi ya pesa taslimu | -536.50M | -58.58% |
Mtiririko huru wa pesa | -42.79M | -121.30% |
Kuhusu
Hypera Pharma is a Brazilian multinational pharmaceutical
company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
Ilianzishwa
2001
Makao Makuu
Tovuti
Wafanyakazi
10,481
